Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Johnson & Johnson to provide 220M COVID-19 vaccine doses to African Union

By Chris Newmarker | March 29, 2021

African Union Johnson & Johnson COVID-19 vaccine

Flag of the African Union

Johnson & Johnson (NYSE:JNJ) announced today that it has entered into an agreement with the African Vaccine Acquisition Trust (AVAT)  to make 220 million COVID-19 vaccine doses available to the 55 African Union member countries.

AVAT also has the potential to order an additional 180 million doses to bring the total to 440 million through 2022. J&J’s move comes as experts increasingly warn that the rollout of COVID-19 vaccine must be truly global — and not too focused on wealthy countries. Otherwise, the pandemic could stretch on for years as new virus variants increasingly crop up in poorer countries.

J&J is also supporting COVAX, a global initiative to provide vaccine doses to developing countries.

“From the beginning of this pandemic, Johnson & Johnson has recognized that no one is safe until everyone is safe, and we have been committed to equitable, global access to new COVID-19 vaccines,” J&J CEO Alex Gorsky said in a news release. “Our support for the COVAX Facility, combined with supplementary agreements with countries and regions, will help accelerate global progress toward ending the COVID-19 pandemic.”

Aspen Pharmacare in South Africa will help support vaccine shipments to African Union member states and will also contribute to worldwide vaccine availability.

 

 

Tell Us What You Think! Cancel reply

Related Articles Read More >

vaccine vial
How end-to-end visibility and machine learning can safeguard the vaccine supply chain
Johnson & Johnson
Johnson & Johnson COVID-19 vaccine shipments plunge
Emergent Biosolutions
Emergent reportedly had serious problems at Baltimore vaccine plant
Canadian flag Canada Sanofi influenza vaccine
Sanofi to spend nearly $700M on new flu vaccine plant in Canada

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards